Changes

Jump to navigation Jump to search
155 bytes added ,  14:11, 25 August 2010
Line 69: Line 69:     
PT is affected by abnormalities or deficiencies in coagulation factors I, II, VII or X, for example in DIC, liver disease, or poisoning with vitamin K antagonists. Inherited defects are possible. PT is also prolonged by the presence of circulating anticoagulants. Inhibitors are often directed at factor X or thrombin and can include fibrin degradation products or heparin<sup>3</sup>.
 
PT is affected by abnormalities or deficiencies in coagulation factors I, II, VII or X, for example in DIC, liver disease, or poisoning with vitamin K antagonists. Inherited defects are possible. PT is also prolonged by the presence of circulating anticoagulants. Inhibitors are often directed at factor X or thrombin and can include fibrin degradation products or heparin<sup>3</sup>.
 +
 +
===Tests for Individual Clotting Factors===
 +
 +
Some specialised laboratories offer tests for specific clotting factors. A sodium citrate sample is required
    
===PIVKA===
 
===PIVKA===
6,502

edits

Navigation menu